Clinical Trial

Multimodal Prediction of Response to Chemoradiotherapy for Squamous Cell Carcinoma of the Head and Neck

Name: Multimodal Prediction of Response to Chemoradiotherapy for Squamous Cell Carcinoma of the Head and Neck — clinical trial record (NCT07259915)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MULTINECK

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The goal of the study lies in offering a multimodal analysis of the post-therapeutic response based on both quantitative parameters and radiomics (CT, MRI, and PET imaging), and on tumor biology, in particular the hypersensitive detection of tumor DNA.

Trial Details

NCT Number	NCT07259915
Lead Sponsor	Centre Henri Becquerel
Conditions	Squamous Cell Cancer of Head and Neck (SCCHN)
Enrollment	152 participants
Start Date	2025-12-01
Primary Completion	2030-08-01 (estimated)
Study Completion	2030-08-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-02